Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 14 EU countries
Case study: Market Access for Preeclampsia Predictive Tests in Germany and Norway
Advance your understanding of European market access for IVD tests
Recent news and posts
Regular update of the Norwegian Laboratory Code System released
On May 22, 2026, the Norwegian Directorate of Health released an updated version of the Norwegian Laboratory Code (NLK) system (Norsk laboratoriekodeverk, v.80) and associated tariffs (Laboratoriekodeverk som gir rett til refusjon) for state and private laboratories to be implemented no later than September 1, 2026. The NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.
A total of 23 new codes were added, 28 codes were changed, and 2 codes were removed.
Some examples of newly introduced codes are provided below:
- NPU26906 P-ApoB/ApoA-1 (ratio);
- NPU62272 P-DFS 70 IgG;
- NPU57888 U-Neisseria gonorrhoeae RNA;
- NPU57890 U-Chlamydia trachomatis RNA.
The letters at the beginning of the code description stand for sample type: P – plasma, U – urine.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.